他汀类药物否定论：一场由互联网驱动的有害思潮，后果致命。 - Suppr

Suppr

超能文献

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

作者信息

Nissen Steven E

机构信息

From Cleveland Clinic, Cleveland, Ohio.

出版信息

Ann Intern Med. 2017 Aug 15;167(4):281-282. doi: 10.7326/M17-1566. Epub 2017 Jul 25.

DOI:10.7326/M17-1566

PMID:28738422

Abstract

摘要

相似文献

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Ann Intern Med. 2017 Aug 15;167(4):281-282. doi: 10.7326/M17-1566. Epub 2017 Jul 25.

Hyperlipidaemia and cardiovascular disease: statin update.

Curr Opin Lipidol. 2007 Jun;18(3):381-3. doi: 10.1097/MOL.0b013e328157455f.

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Ann Intern Med. 2018 Mar 6;168(5):381-382. doi: 10.7326/L17-0624.

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Ann Intern Med. 2018 Mar 6;168(5):382. doi: 10.7326/L17-0625.

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Ann Intern Med. 2018 Mar 6;168(5):381-382. doi: 10.7326/L17-0626.

Statins.

Nurs Stand. 2014 Aug 26;28(51):61. doi: 10.7748/ns.28.51.61.s45.

Over-the-counter statins? Sorting out the issues.

J Cardiovasc Nurs. 2004 Nov-Dec;19(6):430-1. doi: 10.1097/00005082-200411000-00017.

Hyperlipidaemia and cardiovascular disease: low HDL-cholesterol as a therapeutic target in statin-treated patients: a role for nicotinic acid (niacin)?

Curr Opin Lipidol. 2010 Apr;21(2):161-2. doi: 10.1097/MOL.0b013e32833768ea.

Statin Intolerance and Suboptimal Statin Therapy.

J Atheroscler Thromb. 2019 May 1;26(5):403-405. doi: 10.5551/jat.ED106. Epub 2018 Nov 22.

[HMG-CoA reductase inhibitors (statin)].

Nihon Rinsho. 2007 Jul 28;65 Suppl 7:458-64.

引用本文的文献

Aging and liver health: liver chemistries and associated factors in community-dwelling older adults.

BMC Geriatr. 2025 Aug 23;25(1):658. doi: 10.1186/s12877-025-06329-2.

2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP).

Drugs. 2024 Dec;84(12):1541-1577. doi: 10.1007/s40265-024-02105-5. Epub 2024 Nov 4.

Reducing Cardiovascular Disease-An Alternative Approach.

Cardiovasc Drugs Ther. 2024 Dec;38(6):1083-1087. doi: 10.1007/s10557-024-07600-1. Epub 2024 Jul 8.

Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022.

J Am Heart Assoc. 2024 Apr 2;13(7):e032678. doi: 10.1161/JAHA.123.032678. Epub 2024 Mar 27.

Influenza vaccination and use of lipid lowering therapies in adults with atherosclerotic cardiovascular disease: An analysis of the Behavioral Risk Factor Surveillance System (BRFSS).

Am Heart J. 2024 Feb;268:1-8. doi: 10.1016/j.ahj.2023.11.007. Epub 2023 Nov 11.

Challenges in Improving Adherence to Diet and Drug Treatment in Hypercholesterolemia Patients.

Int J Environ Res Public Health. 2023 May 19;20(10):5878. doi: 10.3390/ijerph20105878.

Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy.

Cureus. 2023 May 1;15(5):e38391. doi: 10.7759/cureus.38391. eCollection 2023 May.

Management of patients with statin intolerance.

Best Pract Res Clin Endocrinol Metab. 2023 May;37(3):101714. doi: 10.1016/j.beem.2022.101714. Epub 2022 Oct 18.

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness.

Am J Prev Cardiol. 2022 Aug 6;12:100371. doi: 10.1016/j.ajpc.2022.100371. eCollection 2022 Dec.

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Lancet. 2022 Sep 10;400(10355):832-845. doi: 10.1016/S0140-6736(22)01545-8. Epub 2022 Aug 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

作者信息

Nissen Steven E

机构信息

From Cleveland Clinic, Cleveland, Ohio.

出版信息

Ann Intern Med. 2017 Aug 15;167(4):281-282. doi: 10.7326/M17-1566. Epub 2017 Jul 25.

DOI:10.7326/M17-1566

PMID:28738422

Abstract

摘要

相似文献

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Ann Intern Med. 2017 Aug 15;167(4):281-282. doi: 10.7326/M17-1566. Epub 2017 Jul 25.

Hyperlipidaemia and cardiovascular disease: statin update.

Curr Opin Lipidol. 2007 Jun;18(3):381-3. doi: 10.1097/MOL.0b013e328157455f.

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Ann Intern Med. 2018 Mar 6;168(5):381-382. doi: 10.7326/L17-0624.

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Ann Intern Med. 2018 Mar 6;168(5):382. doi: 10.7326/L17-0625.

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Ann Intern Med. 2018 Mar 6;168(5):381-382. doi: 10.7326/L17-0626.

Statins.

Nurs Stand. 2014 Aug 26;28(51):61. doi: 10.7748/ns.28.51.61.s45.

Over-the-counter statins? Sorting out the issues.

J Cardiovasc Nurs. 2004 Nov-Dec;19(6):430-1. doi: 10.1097/00005082-200411000-00017.

Hyperlipidaemia and cardiovascular disease: low HDL-cholesterol as a therapeutic target in statin-treated patients: a role for nicotinic acid (niacin)?

Curr Opin Lipidol. 2010 Apr;21(2):161-2. doi: 10.1097/MOL.0b013e32833768ea.

Statin Intolerance and Suboptimal Statin Therapy.

J Atheroscler Thromb. 2019 May 1;26(5):403-405. doi: 10.5551/jat.ED106. Epub 2018 Nov 22.

[HMG-CoA reductase inhibitors (statin)].

Nihon Rinsho. 2007 Jul 28;65 Suppl 7:458-64.

引用本文的文献

Aging and liver health: liver chemistries and associated factors in community-dwelling older adults.

BMC Geriatr. 2025 Aug 23;25(1):658. doi: 10.1186/s12877-025-06329-2.

Drugs. 2024 Dec;84(12):1541-1577. doi: 10.1007/s40265-024-02105-5. Epub 2024 Nov 4.

Reducing Cardiovascular Disease-An Alternative Approach.

Cardiovasc Drugs Ther. 2024 Dec;38(6):1083-1087. doi: 10.1007/s10557-024-07600-1. Epub 2024 Jul 8.

Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022.

J Am Heart Assoc. 2024 Apr 2;13(7):e032678. doi: 10.1161/JAHA.123.032678. Epub 2024 Mar 27.

Influenza vaccination and use of lipid lowering therapies in adults with atherosclerotic cardiovascular disease: An analysis of the Behavioral Risk Factor Surveillance System (BRFSS).

Am Heart J. 2024 Feb;268:1-8. doi: 10.1016/j.ahj.2023.11.007. Epub 2023 Nov 11.

Challenges in Improving Adherence to Diet and Drug Treatment in Hypercholesterolemia Patients.

Int J Environ Res Public Health. 2023 May 19;20(10):5878. doi: 10.3390/ijerph20105878.

Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy.

Cureus. 2023 May 1;15(5):e38391. doi: 10.7759/cureus.38391. eCollection 2023 May.

Management of patients with statin intolerance.

Best Pract Res Clin Endocrinol Metab. 2023 May;37(3):101714. doi: 10.1016/j.beem.2022.101714. Epub 2022 Oct 18.

Am J Prev Cardiol. 2022 Aug 6;12:100371. doi: 10.1016/j.ajpc.2022.100371. eCollection 2022 Dec.

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Lancet. 2022 Sep 10;400(10355):832-845. doi: 10.1016/S0140-6736(22)01545-8. Epub 2022 Aug 29.